Structures by: Franzblau S. G.

Total: 10

Dihydroparthenolide diol

C15H24O5

Rugutt, Joseph K.Fronczek, Frank R.Franzblau, Scott G.Warner, Isiah M.

Acta Crystallographica Section E (2001) 57, 4 o323-o325

a=9.2706(13)Å   b=10.4565(8)Å   c=15.094(3)Å

α=90°   β=90°   γ=90°

?

C18H14Cl1F3N2O2

Yujie ZhaoAdelbert BacherBoris IllarionovMarkus FischerGunda GeorgQi-Zhuang YePhillip E. FanwickScott G. FranzblauBaojie WanMark Cushman

Journal of Organic Chemistry (2009) 74, 5297-5303

a=15.9749(2)Å   b=16.4925(3)Å   c=27.4117(6)Å

α=81.5285(7)°   β=82.2566(7)°   γ=89.0766(14)°

C27H35BrO3

C27H35BrO3

Amy L. LaneElizabeth P. StoutMark E. HayAnne C. PrusakKenneth HardcastleCraig R. FairchildScott G. FranzblauKarine Le RochJacques PrudhommeWilliam AalbersbergJulia Kubanek

Journal of Organic Chemistry (2007) 72, 7343-7351

a=11.3840(13)Å   b=10.6382(12)Å   c=20.331(2)Å

α=90.00°   β=90.589(2)°   γ=90.00°

N-Benzyl-3,7-dimethylimidazo[1,2-a]pyridine-2-carboxamide

C17H17N3O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=7.9379(3)Å   b=19.6844(9)Å   c=9.5568(4)Å

α=90.°   β=100.934(2)°   γ=90.°

N-Benzyl-7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide

C15H14N4O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=9.772(3)Å   b=5.8461(19)Å   c=22.078(7)Å

α=90.°   β=91.411(6)°   γ=90.°

N-Benzyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide

C15H15N5O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=20.3189(11)Å   b=10.8268(5)Å   c=15.6023(9)Å

α=90.°   β=129.107(3)°   γ=90.°

N-Benzyl-6-methyl-2H-indazole-3-carboxamide

C16H15N3O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=5.9164(2)Å   b=13.0740(3)Å   c=18.5711(5)Å

α=109.4990(10)°   β=93.229(2)°   γ=94.402(2)°

N-Benzyl-2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamide

C16H16N4O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=9.3005(8)Å   b=6.6121(5)Å   c=11.8267(10)Å

α=90.°   β=106.2760(10)°   γ=90.°

N-Benzyl-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide (1)

C17H17N3O

Garrett C. MoraskiAllen G. OliverLowell D. MarkleySanghyun ChoScott G. FranzblauMarvin J. Miller

Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498

a=4.8686(4)Å   b=15.1351(13)Å   c=19.0283(18)Å

α=94.372(5)°   β=93.841(6)°   γ=93.639(5)°